IPP Bureau
Shilpa Biologicals appoints Dr. Sridevi Khambhampaty as CEO
By IPP Bureau - September 20, 2024
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
Aurobindo Pharma to acquire balance 49% stake in GLS Pharma
By IPP Bureau - September 19, 2024
Lupin receives USFDA approval for Bumetanide Injection
By IPP Bureau - September 19, 2024
Bumetanide Injection USP (RLD Bumex) had estimated annual sales of USD 20 million in the U.S.
Roche receives USFDA approval for Ocrevus Zunovo for treatment of progressive multiple sclerosis
By IPP Bureau - September 19, 2024
This approval is backed by a decade of proven safety and efficacy data of Ocrevus® IV, with over 350,000 people treated globally
Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis
By IPP Bureau - September 19, 2024
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
Brinton Pharmaceuticals launches UV DOUX lip lightening balm in India
By IPP Bureau - September 18, 2024
Coupled with Shea Butter, Cocoa Butter, and Mango Butter, the balm provides deep hydration, ensuring lips remain soft, smooth, and well-moisturized throughout the day
Astec Lifesciences appoints Prof. G. D. Yadav as Independent Director
By IPP Bureau - September 18, 2024
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
Suven Life Sciences announces positive topline results from Phase-2 PoC signal detection open label study of Ropanicant
By IPP Bureau - September 18, 2024
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
Briefs: Eugia Steriles and Shelter Pharma
By IPP Bureau - September 18, 2024
Eugia Steriles receives EIR from USFDA for new injectable facility
Lupin inks licensing agreement with Takeda to commercialize Vonoprazan
By IPP Bureau - September 18, 2024
Takeda has granted Lupin non-exclusive patent licensing rights to commercialize Vonoprazan in India
Aragen receives SBTi approval for its greenhouse gas emission reduction targets
By IPP Bureau - September 17, 2024
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
Merck and Siemens partner on digital transformation technology
By IPP Bureau - September 17, 2024
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
Panacea Biotec and Sanofi reached settlement agreement for Shan6
By IPP Bureau - September 17, 2024
Sanofi would not manufacture or market any product which infringes the amended claims of Panacea patent, IN272351
Alembic appoints Sudhakar Pandiyan as Head - Technical Operations
By IPP Bureau - September 17, 2024
He has been associated with Caplin Steriles Ltd., Mylan Laboratories Ltd., Caplin Point Laboratories Ltd., Strides Arcolab Ltd. and Novartis Vaccines and Diagnostics
Piramal Pharma's GHG Commitment Validated and Approved by SBTi
By IPP Bureau - September 17, 2024
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
